Literature DB >> 9187664

DNA polymorphisms in the 5'-flanking region of the human tissue kallikrein gene.

Q Song1, J Chao, L Chao.   

Abstract

Human tissue kallikrein gene polymorphisms were identified in the promoter region by polymerase chain reaction (PCR) and DNA sequencing. One polymorphic region was identified between nucleotides -121 and -133 with respect to the transcription initiation site of the tissue kallikrein gene. Ten alleles with length and nucleotide sequence variations were detected among 108 unrelated Caucasians, African-Americans, and Asians. The polymorphisms show Hardy-Weinberg equilibrium. Allele-specific amplification and PCR analyses were used to detect the various forms of polymorphism. The promoter activity was analyzed in human embryonic kidney 293 cells by transient transfection assays. Sequential 5'-deletion analysis of the tissue kallikrein gene promoter revealed that the region from -144 to -98 is crucial for its promotor activity, while alleles D and H had significantly lower promoter activities than the other alleles in the -940/+10 deletion constructs. The high variability and the proximity to the tissue kallikrein gene render it suitable for application as a new tool in genetic studies for evaluation of the tissue kallikrein gene in the pathogenesis of human essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187664     DOI: 10.1007/pl00008703

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  A copy number variation in human NCF1 and its pseudogenes.

Authors:  Tiffany Brunson; Qingwei Wang; Isfahan Chambers; Qing Song
Journal:  BMC Genet       Date:  2010-02-23       Impact factor: 2.797

2.  Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia.

Authors:  H K Wang; H C Fung; W C Hsu; Y R Wu; J C Lin; L S Ro; K H Chang; F J Hwu; Y Hsu; S Y Huang; G J Lee-Chen; C M Chen
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

3.  Association of functional kallikrein-1 promoter polymorphisms and acute kidney injury: a case-control and longitudinal cohort study.

Authors:  Paweena Susantitaphong; Mary C Perianayagam; Sun Woo Kang; Wenyi Zhang; Fangwen Rao; Daniel T O'Connor; Bertrand L Jaber
Journal:  Nephron Clin Pract       Date:  2013-04-25

Review 4.  Kidney disease in African Americans: genetic considerations.

Authors:  Deborah A Price; Errol D Crook
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

5.  Renal kallikrein excretion and epigenetics in human acute kidney injury: expression, mechanisms and consequences.

Authors:  Sun Woo Kang; Pei-An Betty Shih; Roy O Mathew; Manjula Mahata; Nilima Biswas; Fangwen Rao; Liying Yan; Josee Bouchard; Rakesh Malhotra; Ashita Tolwani; Srikrishna Khandrika; Ravindra L Mehta; Daniel T O'Connor
Journal:  BMC Nephrol       Date:  2011-06-16       Impact factor: 2.388

Review 6.  Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes.

Authors:  Ana Carolina B Stefanini; Bianca Rodrigues da Cunha; Tiago Henrique; Eloiza H Tajara
Journal:  Dis Markers       Date:  2015-12-09       Impact factor: 3.434

7.  References for Haplotype Imputation in the Big Data Era.

Authors:  Wenzhi Li; Wei Xu; Qiling Li; Li Ma; Qing Song
Journal:  Mol Biol (Los Angel)       Date:  2015-10-31

8.  Association of serum levels of AngII, KLK1, and ACE/KLK1 polymorphisms with acute myocardial infarction induced by coronary artery stenosis.

Authors:  Shu-hong Dai; Ji-fu Li; Jin-bo Feng; Rui-jian Li; Chuan-bao Li; Zhuo Li; Yun Zhang; Da-qing Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-06-21       Impact factor: 1.636

Review 9.  Human tissue kallikrein in the treatment of acute ischemic stroke.

Authors:  Michelle Alexander-Curtis; Rick Pauls; Julie Chao; John J Volpi; Philip M Bath; Todd A Verdoorn
Journal:  Ther Adv Neurol Disord       Date:  2019-01-20       Impact factor: 6.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.